Get the Stockscreener App
27.88
1.56%
0.42
Artivion Inc stock is traded at $27.88, with a volume of 54,677.
It is up +1.56% in the last 24 hours and up +5.47% over the past month.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.
See More
Previous Close:
$27.46
Open:
$27.34
24h Volume:
54,677
Relative Volume:
0.26
Market Cap:
$1.16B
Revenue:
$354.00M
Net Income/Loss:
$-30.69M
P/E Ratio:
-39.83
EPS:
-0.7
Net Cash Flow:
$11.40M
1W Performance:
+4.33%
1M Performance:
+5.47%
6M Performance:
+33.24%
1Y Performance:
+95.97%
1-Day Range:
$27.34
$27.90
1-Week Range:
$26.00
$27.90
52-Week Range:
$13.18
$29.24
Artivion Inc Stock (AORT) Company Profile
Name
Artivion Inc
Sector
Industry
Phone
(770) 419-3355
Address
1655 ROBERTS BOULEVARD N W, KENNESAW
Artivion Inc Stock (AORT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-27-22 | Reiterated | Lake Street | Buy |
| Aug-08-22 | Initiated | Lake Street | Buy |
| Mar-03-22 | Initiated | Stifel | Buy |
Artivion Inc Stock (AORT) Latest News
Artivion (AORT) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
Artivion started at market outperform by JMP, stent graft devices cited - MSN
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results - StockTitan
Artivion (NYSE:AORT) Shares Gap UpHere's Why - MarketBeat
The Latest Analyst Ratings For Artivion - Benzinga
JMP Securities Initiates Coverage on Artivion (NYSE:AORT) - MarketBeat
JMP bullish on Artivion stock, cites EBITDA growth and advanced stent graft division - Investing.com
Artivion (NYSE:AORT) delivers shareholders splendid 111% return over 1 year, surging 5.7% in the last week alone - Simply Wall St
Artivion reports positive trial results for aortic treatments - Investing.com
Artivion reports positive trial results for aortic treatments By Investing.com - Investing.com UK
Artivion Announces Presentation of Late-Breaking Clinical Data at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting - PR Newswire
Artivion Inc (AORT) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Artivion executive sells over $325k in company stock - Investing.com
Artivion executive sells over $325k in company stock By Investing.com - Investing.com South Africa
Amy Horton Sells 12,430 Shares of Artivion, Inc. (NYSE:AORT) Stock - MarketBeat
Dimensional Fund Advisors LP Sells 25,701 Shares of Artivion, Inc. (NYSE:AORT) - MarketBeat
Perceptive Advisors LLC Has $71.66 Million Stock Holdings in Artivion, Inc. (NYSE:AORT) - MarketBeat
Artivion (NYSE:AORT) Trading 5.9% Higher - MarketBeat
Artivion Inc (AORT) Shares Up 5.22% on Sep 27 - GuruFocus.com
Artivion (NYSE:AORT) Receives Buy Rating from Needham & Company LLC - MarketBeat
Those who invested in Artivion (NYSE:AORT) a year ago are up 61% - Yahoo Finance
Can Artivion's Strong Vital Signs Lead To Further Stock Gains? - RTTNews
Check Out Artivion Inc (AORT)’s Trade Data Rather Than the Analysts’ Views - SETE News
First Eagle Investment Management LLC Acquires 27,906 Shares of Artivion, Inc. (NYSE:AORT) - MarketBeat
Atkore Inc. to Attend the 2024 RBC Capital Markets Global Industrials Conference - sharewise
(AORT) Trading Signals - Stock Traders Daily
RedTech gives two minutes to Axel Technology - RedTech
Arlington's AeroVironment facing protest to massive Army contract - The Business Journals
Hearts hoping to cash in on Bloom’s formula - Daily Business
Hearts in talks with Brighton chairman Tony Bloom over £10m plan to revolutionise recruitment at Tynecastle, with a view to buying a minority stake in the club - MSN
Atlanta police sergeant accidentally shoots himself, taken to Grady Memorial Hospital - WSB Atlanta
Artivion (NYSE:AORT) Price Target Raised to $30.00 - Defense World
Aortic Stenosis Market Rewriting Long Term Growth Story: Abbott, Artivion, Medtronic - openPR
'Chemical decomposition' reported at Arkema Geneseo plant - The Livingston County News
Analyst Scoreboard: 5 Ratings For Artivion - Benzinga
Artivion (NYSE:AORT) Shares Gap Up After Analyst Upgrade - MarketBeat
Tech company to relocate headquarters to Florence County, create 70+ new jobs - wpde.com
Is Now An Opportune Moment To Examine Artivion, Inc. (NYSE:AORT)? - Yahoo Finance
Should You Invest in Artivion (AORT)? - Yahoo Finance UK
Artivion exec sells shares worth over $84k - Investing.com
This Insider Has Just Sold Shares In Artivion - Simply Wall St
Artivion Inc (AORT) rating reiterates by Lake Street - Knox Daily
Artivion, Inc. (NYSE:AORT) VP Sells $238,420.20 in Stock - MarketBeat
Short Interest in Artivion, Inc. (NYSE:AORT) Rises By 6.2% - MarketBeat
AORT (Artivion) Cash Flow for Lease Financing : $0.0 Mil (TTM As of Jun. 2024) - GuruFocus.com
AORT (Artivion) Enterprise Value : $1,356.0 Mil (As of Aug. 17, 2024) - GuruFocus.com
Artivion executive sells over $61k in company stock By Investing.com - Investing.com Australia
Anthony B. Semedo Sells 9,709 Shares of Artivion, Inc. (NYSE:AORT) Stock - Defense World
Artivion, Inc. (NYSE:AORT) SVP Sells $61,386.08 in Stock - MarketBeat
Artivion executive sells over $61k in company stock - Investing.com
Artivion director Semedo sells shares worth over $240k By Investing.com - Investing.com Australia
Artivion Inc Stock (AORT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
0.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):